CALIBRATE-PEDS: a phase 2/3, multicenter, single-arm study evaluating the pharmacokinetics, efficacy, and safety of encaleret in pediatric participants with autosomal dominant hypocalcemia type 1Stefano Mora, Rachel I. Gafni, R. Todd Alexander et al.|Endocrine Abstracts|2025Cited by 0